Top compounds associated with response to OR2L13


Feature Type Standardized
Nominal ANOVA
mRNA AP-24534 GDSC1000 pan-cancer AAC 0.061 0.06
mRNA Tamoxifen GDSC1000 pan-cancer AAC -0.061 0.06
mRNA NSC23766 CTRPv2 pan-cancer AAC -0.063 0.06
mRNA YL54 CTRPv2 pan-cancer AAC 0.071 0.06
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.064 0.06
mRNA BHG712 GDSC1000 pan-cancer AAC 0.053 0.06
mRNA PD 153035 CTRPv2 pan-cancer AAC -0.075 0.06
mRNA TL-1-85 GDSC1000 pan-cancer AAC 0.054 0.07
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.063 0.07
mRNA BMS-270394 CTRPv2 pan-cancer AAC -0.066 0.07
Download CSV